A wave of new drugs to treat heart diseases is starting to reach patients, as drugmakers work to revive a $48 billion category that once powered the industry
The once lucrative heart-drug market is now poised to make a comeback, but at the cost of heavy investments in research and deal making.
After watching lower-priced generics seize sales of once-highflying blood-pressure, cholesterol and other heart drugs, companies struggled to discover replacements and then win reimbursement for five-figure prices. Drugmakers are now rolling out new medicines, though their commercial prospects are uncertain.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Love Will Be In The Air This Week, Astrologers Predict: Here's WhySelf-expression is the name of the game this week as the annual Leo new moon fills the sky. Here's what to expect. 🌑
Read more »
U.S. new home sales fall in June to the lowest level since the pandemicNew home sales fell 8.1% to 590,000 in June, according to the Commerce Department.
Read more »
One barrier to electric cars: Slow fleet turnoverNew research shows why strong sales growth is not enough to reach climate targets.
Read more »
Boost Mobile obliterates the competition with the cheapest 'unlimited' plan in the USBoost Mobile has quietly launched a killer new promotion for new customers allowing you to get unlimited 'everything' for just $25 a month.
Read more »
Zebrafish Can Repair a Damaged Heart, And a New Study Reveals HowZebrafish are marvelous creatures. Not only are they completely see-through, but they can also grow new organs. We already knew these translucent little fish could regenerate retinal tissue in their eyes – now new research shows how zebrafish can
Read more »
Priced-out locals account for more than a third of available NYC rentalsNew York City’s scarce rental inventory has gotten slightly better, according to a new StreetEasy market report, but it seems due to tenants being priced out of COVID deals.
Read more »